What myLaurel does

myLaurel (legal entity Nobis, LLC d/b/a myLaurel) is a New York–based, venture-backed healthcare services company founded in 2016 that delivers hospital-level acute and transitional care in patients' homes. The company operates three integrated service lines — Acute Care at Home, Rapid Advanced Care (90-minute response for high-acuity symptoms), and Recovery at Home (14–30 day post-discharge transitional care) — combining field responders, in-home point-of-care diagnostics (blood tests, 12-lead EKG, ultrasound, viral screenings), telehealth providers, and a proprietary care coordination platform called CareDash. Underlying operations are supported by AI-powered logistics designed to dispatch clinical teams to a patient's home within 90 minutes of referral.

myLaurel sells exclusively to enterprise customers — U.S. health systems, health plans (including Medicare Advantage and risk-bearing entities), and PACE programs — and does not operate a direct-to-consumer channel. The business model is 100% at-risk: fees are contingent on successful patient outcomes, and if a patient requires hospitalization or an ED visit during the risk window, myLaurel is not paid. Contracts are multi-year and structured around reducing 30-day readmissions, ED diversion, length of stay, and overall cost of care for high-complexity, frail, and elderly populations.

The go-to-market is enterprise field sales targeting health system CFOs, CEOs, and clinical leaders, as well as health plan decision-makers. Named anchor partners include Ochsner Health, Maimonides Health, and University Medical Center New Orleans, with participation in thought leadership alongside Jefferson Health, Tampa General Hospital, and Providence Health. Reported outcomes include a 49% reduction in 30-day readmissions (versus a matched control), 91% of patients bypassing hospitalization, a 97 NPS, and a minimum 3:1 ROI for partners within the first 90 days. The company is HIPAA-compliant, operates exclusively in the United States, and has raised disclosed equity exceeding $118M since inception from investors including Deerfield Management, Google Ventures, SteelSky Ventures, City Light Capital, Frist Cressey Ventures, Town Hall Ventures, Acumen, and Emerson Collective.

Name

myLaurel

Legal name

Nobis, LLC d/b/a myLaurel

Website

https://mylaurelhealth.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

101–250 employees

Short description

myLaurel delivers hospital-level acute and transitional care in patients' homes under 100% at-risk contracts with U.S. health systems and health plans, serving high-complexity and elderly populations to reduce hospitalizations, readmissions, and bed capacity strain.

Ownership category

akta.pro rank

Product category

Acute Home Healthcare Services

NAICS

Home Health Care Services (62161), Ambulatory Health Care Services (621)

SIC

Services-Home Health Care Services (8082), Services-Health Services (8000)

akta.pro primary industry

Hospital-at-Home & Acute Virtual Care Platforms (HLALABAC)

akta.pro secondary industries

Post-Acute & Transitional Care Virtual Platforms (SNF/home health coordination) (HLALABAG), Hospital-at-Home & Acute-at-Home Remote Monitoring (step-down, escalation workflows) (HLALAFAH), Post-Acute & Transitional 24/7 In-Home Care (Hospital/SNF Discharge) (HSABAHAF)

Keywords

• Acute home care
• Transitional care services
• Hospital at home
• In-home clinical care
• Readmission reduction

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. At-Risk Contracts with Health Systems: Health systems pay for acute care at home services under at-risk arrangements where myLaurel's fees are contingent on successful patient outcomes. If patients require hospitalization during the care period, the health system does not pay myLaurel's fees.
2. At-Risk Contracts with Health Plans: Health plans pay under at-risk arrangements where myLaurel goes at risk for outcomes. Services generate cost savings by reducing unnecessary ED visits, observation stays, and inpatient admissions. If patients have an ED or inpatient admission within the risk period, myLaurel does not get paid.
3. PACE Program Partnerships: Partnerships with Program of All-Inclusive Care for the Elderly (PACE) organizations providing in-home acute care for high-complexity elderly patients under at-risk arrangements.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

myLaurel delivers hospital-level acute and transitional care in patients' homes through a hybrid model that combines hands-on clinical visits with telehealth and AI-powered logistics. The company operates three service lines—Acute Care at Home, Rapid Advanced Care (90-minute response), and Recovery at Home (14–30 day post-discharge)—selling exclusively to health systems, health plans, and PACE programs under 100% at-risk, outcome-based contracts.

Product overview

myLaurel is a hybrid care-at-home platform offering three integrated service lines: Acute Care at Home™ provides hospital-level acute care in the patient's home; Rapid Advanced Care™ delivers 90-minute response for acute symptoms to prevent ED visits; and Recovery at Home™ offers 14-30 day post-discharge transitional care to reduce readmissions. All services use a blended model combining in-person clinical visits with telehealth and telephonic follow-up, supported by proprietary care management technology.

Differentiator

Problem solved

Functional benefit

Products and services

• Acute Care at Home Hospital-level acute and transitional care delivered in the patient's home, combining hands-on clinical care with virtual technology. Targeted at health systems and payers serving high-complexity patients to prevent unnecessary hospitalizations, free bed space, and reduce costs.
• Rapid Advanced Care Pre-hospital acute care service providing on-demand treatment for high-acuity symptoms in the patient's home within 90 minutes of referral. Reduces preventable ED and inpatient utilization for health plan and health system partners.
• Recovery at Home Post-discharge transitional care program spanning 14-30 days that minimizes avoidable readmissions through personalized support, medication reconciliation, and continuous care coordination following hospitalization.

Quantifiable outcome

• 49% reduction in 30-day readmissions
• +7 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Seven partnerships are on record, tiered flagship, core and supporting.

• Ochsner HealthflagshipStrategic or Co-development PartnerMajor health system partner operating 46 hospitals and 370+ health and urgent care centers in the Gulf South. myLaurel's Acute Care at Home program is deployed in Ochsner's ED, observation, and inpatient units to reduce readmissions and improve capacity management. Case study customer with published outcomes data.
• Maimonides HealthcoreStrategic or Co-development PartnerBrooklyn-based health system partner implementing myLaurel's hospital-at-home care model. CMO Dr. John Marshall has publicly endorsed the partnership anticipating improved patient recovery outcomes.
• University Medical Center New OrleanscoreStrategic or Co-development PartnerNew Orleans hospital implementing myLaurel's care-at-home services as part of commitment to improving patient experience and enabling recovery at home.
• Jefferson HealthcoreStrategic or Co-development PartnerExecutive panel webinar participant with myLaurel discussing how health systems are unlocking capacity and driving financial performance with care-at-home models.
• Tampa General HospitalcoreStrategic or Co-development PartnerExecutive panel webinar participant with myLaurel discussing scaling acute care at home as an operational standard for hospital capacity management.
• Providence HealthcoreStrategic or Co-development PartnerExecutive panel participant in white paper discussion on capacity constraints and scaling acute care at home. Senior clinical executives contributed to myLaurel's thought leadership.
• Humbi AIsupportingTechnology or IntegrationIndependent consultant partner that collected and validated data for myLaurel's PACE program case study (494 patients, April 2022 - November 2023) demonstrating 6:1 ROI and clinical outcomes.

Scale indicators13 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Amedisys: Amedisys is one of the largest U.S. home health and hospice providers, with growing hospital-at-home capabilities via its Contessa acquisition. It overlaps with myLaurel on post-acute and home-based skilled care delivery.
• LHC Group: LHC Group is a large national home health and post-acute provider (now part of UnitedHealth Group/Optum). It is broadly comparable to myLaurel on home health and transitional care delivery, though it operates at much larger scale and via traditional fee-for-service contracts.
• CenterWell Home Health (Humana): Humana's CenterWell is a large home health and primary care provider serving Medicare Advantage populations, including complex and post-acute patients. It is a broader incumbent with overlapping capabilities in home-based acute and transitional care.

Emerging players

• Vivify Health: Vivify Health provides remote patient monitoring and virtual care platforms used by health plans and providers to manage chronic and post-acute populations at home. It is comparable to myLaurel on the post-discharge and chronic-condition management use case.
• Current Health (Best Buy Health): Current Health, owned by Best Buy Health, offers a remote patient monitoring and care-at-home platform used by health systems for acute and post-acute care. It competes with myLaurel on the technology layer supporting in-home acute care delivery.
• Biofourmis: Biofourmis provides AI-driven remote monitoring and hospital-at-home capabilities, with FDA-cleared analytics for acute care. It overlaps with myLaurel on the technology-enabled acute-at-home and post-discharge monitoring use cases.

Regional players

• Heal (Humana): Heal, now part of Humana, provides in-home primary, urgent, and post-acute care, originally focused on specific U.S. markets. It is comparable to myLaurel on in-home care delivery for complex and post-discharge patients, though with a different geographic footprint.

Direct peers

• DispatchHealth: DispatchHealth delivers hospital-level acute care in the home, including ED avoidance and post-discharge transitional care, with health system and payer partnerships. It is the most direct competitor to myLaurel's Acute Care at Home and Rapid Advanced Care lines.
• Medically Home: Medically Home operates a hospital-at-home platform enabling health systems to deliver acute and post-acute care in the home, with a virtual command center and in-home clinician network that directly overlaps myLaurel's care model.
• Contessa Health (Amedisys): Contessa Health pioneered hospital-at-home and skilled nursing facility-at-home programs for health systems and payers, and is now part of Amedisys. It competes head-to-head with myLaurel on acute and transitional care-at-home contracts.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/mylaurel

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds9 records

Investors17 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about myLaurel